JP2024540168A5 - - Google Patents

Info

Publication number
JP2024540168A5
JP2024540168A5 JP2024525613A JP2024525613A JP2024540168A5 JP 2024540168 A5 JP2024540168 A5 JP 2024540168A5 JP 2024525613 A JP2024525613 A JP 2024525613A JP 2024525613 A JP2024525613 A JP 2024525613A JP 2024540168 A5 JP2024540168 A5 JP 2024540168A5
Authority
JP
Japan
Prior art keywords
quality control
nucleoside
dna
conversion
adapter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540168A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079173 external-priority patent/WO2023081722A2/en
Publication of JP2024540168A publication Critical patent/JP2024540168A/ja
Publication of JP2024540168A5 publication Critical patent/JP2024540168A5/ja
Pending legal-status Critical Current

Links

JP2024525613A 2021-11-02 2022-11-02 品質管理方法 Pending JP2024540168A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163274868P 2021-11-02 2021-11-02
US63/274,868 2021-11-02
PCT/US2022/079173 WO2023081722A2 (en) 2021-11-02 2022-11-02 Quality control method

Publications (2)

Publication Number Publication Date
JP2024540168A JP2024540168A (ja) 2024-10-31
JP2024540168A5 true JP2024540168A5 (https=) 2025-11-10

Family

ID=84367177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525613A Pending JP2024540168A (ja) 2021-11-02 2022-11-02 品質管理方法

Country Status (4)

Country Link
US (1) US20240093292A1 (https=)
EP (1) EP4426858B1 (https=)
JP (1) JP2024540168A (https=)
WO (1) WO2023081722A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024229143A1 (en) * 2023-05-01 2024-11-07 Guardant Health, Inc. Quality control method for enzymatic conversion procedures
WO2026072949A1 (en) * 2024-09-27 2026-04-02 Roche Sequencing Solutions, Inc. Multi-modal risk stratification of minimum residual disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US20030017081A1 (en) 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
WO2003046146A2 (en) 2001-11-28 2003-06-05 Applera Corporation Compositions and methods of selective nucleic acid isolation
ATE443765T1 (de) 2003-03-21 2009-10-15 Santaris Pharma As Analoga kurzer interferierender rna (sirna)
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
CN104781421B (zh) 2012-09-04 2020-06-05 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
CA2936564C (en) * 2014-01-07 2022-10-18 Fundacio Privada Institut De Medicina Predictiva I Personalitzada Del Cancer Methods for generating double stranded dna libraries and sequencing methods for the identification of methylated cytosines
GB201413318D0 (en) * 2014-07-28 2014-09-10 Cambridge Epigenetix Ltd Nucleic acid sample preparation
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
MX2019007444A (es) 2016-12-22 2019-08-16 Guardant Health Inc Metodos y sistemas para analisis de moleculas de acido nucleico.
WO2020160414A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
KR20220015367A (ko) * 2019-05-31 2022-02-08 프리놈 홀딩스, 인크. 메틸화된 핵산의 고심도 시퀀싱 방법 및 시스템
EP3997245B1 (en) * 2019-07-08 2023-10-18 Ludwig Institute for Cancer Research Ltd Bisulfite-free, whole genome methylation analysis
WO2021178893A2 (en) * 2020-03-06 2021-09-10 Singular Genomics Systems, Inc. Linked paired strand sequencing

Similar Documents

Publication Publication Date Title
JP7136899B2 (ja) シトシン修飾の、亜硫酸水素塩非含有、塩基分解能特定
JP2023544721A5 (https=)
JP2020513801A (ja) メチル化状態が維持されるｄｎａ増幅方法
CN103233072B (zh) 一种高通量全基因组dna甲基化检测技术
Tost Current and emerging technologies for the analysis of the genome-wide and locus-specific DNA methylation patterns
JP2023550141A (ja) 制限酵素及びハイスループット配列決定を用いたｄｎａ試料におけるメチル化変化の検出
CN119421958A (zh) 鉴别癌症的甲基化标志物及应用
JP2024540168A5 (https=)
JP2023547620A5 (https=)
Tost Current and emerging technologies for the analysis of the genome-wide and locus-specific DNA methylation patterns
Wu et al. GlaI cleavage assistant isothermal exponential amplification coupling with CRISPR/Cas12a for ultrasensitive detection of CLDN11 methylation: A potential marker for lung adenocarcinoma
CN115961001B (zh) Dna甲基转移酶结合胞嘧啶脱氨酶介导的dna中5-甲基胞嘧啶的单碱基定位分析方法
US20240301466A1 (en) Efficient duplex sequencing using high fidelity next generation sequencing reads
Kumar et al. Techniques/tools to study epigenetic biomarkers in human cancer detection
JP2024523401A5 (https=)
KR20240046525A (ko) 세포-유리 dna에 대한 tet-보조 피리딘 보란 시퀀싱과 관련된 조성물 및 방법
TW201934568A (zh) 一種用於檢測食道癌的基因標誌物及其用途和檢測方法
Dai et al. Ultrasensitive amplification-free quantification of a methyl CpG-rich cancer biomarker by single-molecule kinetic fingerprinting
CN117778568A (zh) 鉴别胃癌的标志物及应用
KR101683086B1 (ko) 유전자의 발현량 및 메틸화 프로필을 활용한 돼지의 산자수 예측방법
CN119614709B (zh) 一种全基因组5-羟甲基胞嘧啶的检测方法及应用
US20250361549A1 (en) Detection of epigenetic cytosine modification
JP5116939B2 (ja) 哺乳動物由来の検体の癌化度を評価する方法
Weng et al. Methods for mapping of nucleic acids epigenetic modifications and its clinic applications
CN121802045A (zh) 用于鉴别甲状腺乳头状癌侵袭亚型的甲基化标志物、诊断模型及应用